相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Roles of microRNAs in Cancer Multidrug Resistance
Lucia Pavlikova et al.
CANCERS (2022)
Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells
David S. P. Cardoso et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
Tai-Na Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer
Liliana Raimundo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The Natural Products and Extracts: Anti-Triple-Negative Breast Cancer in Vitro
Han Chen et al.
CHEMISTRY & BIODIVERSITY (2021)
The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Sima Singh et al.
DRUG DISCOVERY TODAY (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou et al.
CANCERS (2021)
Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer
David S. P. Cardoso et al.
PHARMACEUTICALS (2021)
Current status and contemporary approaches to the discovery of antitumor agents from higher plants
Garima Agarwal et al.
BIOTECHNOLOGY ADVANCES (2020)
Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
Maryam Majidinia et al.
IUBMB LIFE (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
Mariana Alves Reis et al.
FRONTIERS IN PHARMACOLOGY (2020)
Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer
Ricardo J. Ferreira et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
Ye Han et al.
FRONTIERS IN ONCOLOGY (2020)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Monoterpene indole alkaloid azine derivatives as MDR reversal agents
Angela Paterna et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters
Ricardo J. Ferreira et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Triterpenoids from Momordica balsamina with a Collateral Sensitivity Effect for Tackling Multidrug Resistance in Cancer Cells
Catia Ramalhete et al.
PLANTA MEDICA (2018)
Improving anticancer activity towards colon cancer cells with a new p53-activating agent
Liliana Raimundo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells
Angela Paterna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice
Radim Havelek et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Jatrophane diterpenes and cancer multidrug resistance-ABCB1 efflux modulation and selective cell death induction
Mariana Alves Reis et al.
PHYTOMEDICINE (2016)
Monoterpene indole alkaloid hydrazone derivatives with apoptosis inducing activity in human HCT116 colon and HepG2 liver carcinoma cells
Angela Paterna et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)